UK author of transgender study: U.S. groups are ‘misleading the public’

Michie

Well-Known Member
Site Supporter
Feb 5, 2002
167,663
56,886
Woods
✟4,768,371.00
Country
United States
Faith
Catholic
Marital Status
Married
Politics
US-Others
An English pediatrician who led a comprehensive review of the safety and efficacy of prescribing transgender drugs to children is warning that health associations in the United States may be misleading the public.

In an interview with the New York Times published on Monday, Dr. Hilary Cass warned there is no comprehensive evidence to support the routine prescription of transgender drugs to minors with gender dysphoria.

Cass published the independent “Cass Review,” commissioned by the National Health Service in England, which prompted England and Scotland to halt the prescription of transgender drugs to minors until more research is conducted.

As England, Scotland, and other European countries scale back their use of transgender drugs for minors, most doctors’ associations and health associations in the U.S. continue to endorse these medical interventions. In more than half of the states in the United States, it is still legal to prescribe transgender drugs to children and to perform transgender surgeries on them.

Continued below.